2.Effect of Melatonin during Recovery of Tissue Injury after Intestine Ischemia-Reperfusion.
Yil Young CHEN ; Myung Chun KIM ; Young Gwan KO ; Hyung Hwan BAIK ; Yong Ho CHO
Journal of the Korean Society of Emergency Medicine 2003;14(3):264-272
PURPOSE: It is now well recognized that reperfusion of ischemic tissues initiates a complex series of reactions that can paradoxically injure tissues. Apoptosis occurs in select cell populations during morphologic development and during cellular injury, including oxygen radical exposure, ischemia-reperfusion, and sepsis. Thus, in this study, we examined relation of the melatonin effect to the injection time and the dose, and role of melatonin in apoptosis. METHODS: Intestinal ischemia-reperfusion injury was induced in rats by clamping the superior mesenteric artery for 30 minutes. After reperfusion injury for 30 minutes, the experimental group was administered melatonin (10 mg/kg) intraperitoneally and the control group received saline and ethanol. At 30 minutes, 60 minutes, and 90 minutes, 1) pulmonary histological assessments (interstitial PMNs/10HPFs and lung (alveolar) injury score), 2) alveolar microvascular permeability assessments (wet-weignt to dry-weight ratio and lipid peroxidation activity, malondialdehyde, MDA), and 3) western blotting assessments (p53, p21, Bax, and bcl-2) were made. For comparison, long- time (60-minute) reperfusion and double- dosage melatonin (20 mg/kg) were also studied. RESULTS: The lung injury score was 1.00+/-0 in the melatonin group at 90 minutes and 3.28+/-0.30 in the saline group (p<0.01). The number of sequestered neutrophils was significantly higher in the control group at 90 minutes (34.38+/-16.76/10 HPFs) than in the melatonin-treated group (5.63+/-2.73/10 HPFs; p<0.01). In the melatonin group at 90 minutes, the wet-weight to dry-weight ratio was 4.69+/-0.16, and in the saline group, the ratio was 4.78+/-0.17 (p>0.05). A marked difference was found between the ischemia-reperfusion control group and the experimental group at 90 minutes regarding lipid peroxidation activity (Malondialdehyde, 16.45+/-0.19 micrometer vs 10.93+/-0.11 micrometer, p<0.01). In the melatonin group, p21 expressions were found to be much more than in the control group. But, p53, bcl-2, and Bax expressions were found to be in the control group. CONCLUSION: Melatonin injection within 60 min after reperfusion may promote recovery of reperfusion injury, but double-dose melatonin injection was inefficacious. Also, melatonin inhibit apoptosis by p21 expression.
Animals
;
Apoptosis
;
Blotting, Western
;
Capillary Permeability
;
Constriction
;
Ethanol
;
Intestines*
;
Lipid Peroxidation
;
Lung
;
Lung Injury
;
Malondialdehyde
;
Melatonin*
;
Mesenteric Artery, Superior
;
Neutrophils
;
Oxygen
;
Rats
;
Reperfusion
;
Reperfusion Injury
;
Sepsis
3.Prevalence of the Metabolic Syndrome in Patients with Gout.
Young Hee RHO ; Seong Jae CHOI ; Young Ho LEE ; Jong Dae JI ; Kyung Mook CHOI ; Sei Hyun BAIK ; Gwan Gyu SONG
The Journal of the Korean Rheumatism Association 2004;11(4):349-357
OBJECTIVE: Metabolic syndrome is a constellation of metabolic abnormalities such as obesity, hypertension, glucose intolerance, and hyperlipidemia. The association of metabolic syndrome and hyperuricemia is well known, but not with gout. Therefore, the association of gout and metabolic syndrome is investigated through comparing the prevalence of metabolic syndrome in normal controls and patients with gout. METHODS: This is a case-historical control study of 64 patients with gout recruited from Korea University Anam and Guro Hospital. Clinical factors were checked according to the diagnostic criteria of metabolic syndrome from the ATP III guidelines. Additional waist circumference adjustment was done according to the WHO Asia-Pacific obesity criteria recommendations. The prevalence was compared with historical control studies from the US and Korea. RESULTS: The prevalence of metabolic syndrome in patients with gout was 42.2% according to ATP III criteria and 59.4% with waist circumference adjustment and is significantly higher than control studies (23.7% (US), 6.8% (Korea), ATP III), 10.9% (Korea, WHO Asia-Pacific obesity criteria)(p<0.001 in all cases). Multivariate logistic regression analysis revealed that high BMI and low HDL levels (both ATP III/WHO Asia-Pacific obesity criteria) and the presence of hypertension (ATP III) are the statistically significant risk factors of having metabolic syndrome in gout patients. CONCLUSION: The prevalence of metabolic syndrome in patients with gout is significantly higher than normal control groups. This indicates an association between gout and metabolic syndrome. Especially, being obese or hypertensive, or having low HDL levels are risk factors for the metabolic syndrome in gout patients.
Adenosine Triphosphate
;
Glucose Intolerance
;
Gout*
;
Humans
;
Hyperlipidemias
;
Hypertension
;
Hyperuricemia
;
Korea
;
Logistic Models
;
Obesity
;
Prevalence*
;
Risk Factors
;
Waist Circumference
4.A case of Prune Belly syndrome.
Young Sook KIM ; Byung Sik CHANG ; Hye Jung JOO ; Kook In PARK ; Ran NAMGUNG ; Chul LEE ; Dong Gwan HAN ; Yong Won PARK ; Jae Sung CHO ; Eun Chan BAIK ; Chan Ho SONG
Korean Journal of Perinatology 1992;3(2):84-92
No abstract available.
Prune Belly Syndrome*
5.A case of hepatobronchial fistula in liver abscess.
Myeong Gwan JEE ; Yeun Jong CHOI ; Soon Koo BAIK ; Sang Jin YOON ; Hyun Soo KIM ; Dong Ki LEE ; Young Ju KIM
Korean Journal of Medicine 2003;65(Suppl 3):S703-S706
We report an uncommon case of pyogenic hepatic abscess with hepatobronchial fistula. A 59 year-old male was admitted because of purulent sputum and cough. Ultrasonography and abdominal computed tomography showed an abscess on the superior segment of right hepatic lobe. Diagnostic and therapeutic percutaneous trans-hepatic abscessography disclosed hepatobronchial fistula. Liver abscess with hepatobronchial fistula was managed with percutaneous abscess drainage and antibiotics. The abscess was resolved and he is being on the follow-up with symptom free status.
Abscess
;
Anti-Bacterial Agents
;
Cough
;
Drainage
;
Fistula*
;
Follow-Up Studies
;
Humans
;
Liver Abscess*
;
Liver Abscess, Pyogenic
;
Liver*
;
Male
;
Middle Aged
;
Sputum
;
Ultrasonography
6.A case of hepatobronchial fistula in liver abscess.
Myeong Gwan JEE ; Yeun Jong CHOI ; Soon Koo BAIK ; Sang Jin YOON ; Hyun Soo KIM ; Dong Ki LEE ; Young Ju KIM
Korean Journal of Medicine 2003;65(Suppl 3):S703-S706
We report an uncommon case of pyogenic hepatic abscess with hepatobronchial fistula. A 59 year-old male was admitted because of purulent sputum and cough. Ultrasonography and abdominal computed tomography showed an abscess on the superior segment of right hepatic lobe. Diagnostic and therapeutic percutaneous trans-hepatic abscessography disclosed hepatobronchial fistula. Liver abscess with hepatobronchial fistula was managed with percutaneous abscess drainage and antibiotics. The abscess was resolved and he is being on the follow-up with symptom free status.
Abscess
;
Anti-Bacterial Agents
;
Cough
;
Drainage
;
Fistula*
;
Follow-Up Studies
;
Humans
;
Liver Abscess*
;
Liver Abscess, Pyogenic
;
Liver*
;
Male
;
Middle Aged
;
Sputum
;
Ultrasonography
7.The Effects of Radiation Using Ho-166 on Endothelial Function in a Porcine Coronary Model.
Jay Young RHEW ; Myung Ho JEONG ; Sang Rok LEE ; Young Joon HONG ; Seng Hyun LEE ; Ok Young PARK ; Woo Kon JEONG ; Weon KIM ; Ju Han KIM ; Ju Hyup YUM ; Ho Cheon SONG ; Hee Seung BOM ; Kyung Bae PARK ; Young Keun AHN ; Jeong Gwan CHO ; Jong Chun PARK ; Yung Hong BAIK ; Jung Chaee KANG
Korean Circulation Journal 2002;32(2):118-124
BACKGROUND AND OBJECTIVES: It has been reported that intracoronary radiation therapy (ICRT) using a Ho-166 coated balloon inhibits restenosis of porcine coronary arteries. However, the consequences of ICRT on coronary artery endothelial function are unknown. The aim of this study is to investigate the effects of ICRT using a Ho-166 balloon on coronary artery endothelial function and vasomotor reactivity. MATERIALS AND METHODS: Female pigs (25-35 kg) were orally premedicated daily with aspirin (100 mg) and ticlopidine (250 mg) for the duration of the study. Under sterile conditions with local anesthesia of the skin provided by 2% lidocaine, an arteriotomy of the left carotid artery was performed, an 8 Fr sheath was inserted, and intraarterial heparin sodium (10,000 IU) was injected. Under fluoroscopic guidance, the coronary artery main branch was selected through an 8 Fr guiding catheter for coronary artery overdilation injury (balloon to artery ratio, 1.3:1) and ICRT. A Ho-166 coated balloon prepared to deliver 20 Gy at a depth of 2 mm from the balloon surface was used for ICRT. The coronary artery main branch in each pig was randomly assigned to either balloon injury (Group I) or balloon injury plus ICRT (Group II). Coronary artery segments were taken from the animals at 0 week (n=8), 4 weeks (n=6) and 8 weeks (n=8) after the intervention. Data in each group denote the relative ratio compared to non-injured coronary artery and are expressed as mean +/- standard error of mean. RESULTS: The degree of KCl-induced contractile response (g) was not different between the two groups at 0 and 4 weeks, but was significantly decreased in group II compared to group I at 8 weeks (I:1.04+/-0.06, II:0.79+/-0.07, p=0.014). In rings precontracted with prostaglandin F 2alpha (PGF 2alpha), the degree of NO-dependent relaxation (%) induced with substance P was significantly decreased in group II compared to group I at 0 week (I:0.93+/-0.33, II:0.47+/-0.31, p=0.03), but the difference between the two groups was not significant at 4 and 8 weeks. In rings precontracted with PGF 2alpha and LAME in the presence of indomethacin, the degree of EDHF-induced relaxation (%) using substance P was not different between the two groups at 0, 4 and 8 weeks; nor was the degree of sodium nitroprusside-induced endothelium independent relaxation (%) in depolarized conditions with PGF 2alpha. CONCLUSION: Endothelial function of the porcine coronary artery is only transiently impaired after ICRT using a Ho-166 coated balloon. Therefore this therapy can be used as an effective method to prevent restenosis after percutaneous coronary intervention.
Anesthesia, Local
;
Angioplasty
;
Animals
;
Arteries
;
Aspirin
;
Carotid Arteries
;
Catheters
;
Coronary Restenosis
;
Coronary Vessels
;
Endothelium
;
Female
;
Heparin
;
Humans
;
Indomethacin
;
Lidocaine
;
Percutaneous Coronary Intervention
;
Prostaglandins F
;
Relaxation
;
Skin
;
Sodium
;
Substance P
;
Swine
;
Ticlopidine
8.The Prevalence of Metabolic Syndrome in Patients with Gout: A Multicenter Study.
Young Hee RHO ; Seong Jae CHOI ; Young Ho LEE ; Jong Dae JI ; Kyung Mook CHOI ; Sei Hyun BAIK ; Seung hie CHUNG ; Chae Gi KIM ; Jung Yoon CHOE ; Sung Won LEE ; Won Tae CHUNG ; Gwan Gyu SONG
Journal of Korean Medical Science 2005;20(6):1029-1033
It has been suggested that hyperuricemia and possibly gout are associated with the metabolic syndrome, but there have been no direct studies. This study was undertaken to obtain the prevalence of the metabolic syndrome in patients with gout and to compare it with those from the general population studies. This was a 4-institutional case-historical control study composed of 168 patients with gout. We assessed the prevalence of metabolic syndrome according to the ATP III criteria and compared the prevalence with that of the historical controls. To elucidate the factors in gout that were associated with metabolic syndrome, a multivariate analysis was done. The age-adjusted prevalence of metabolic syndrome in gout patients was 43.6%, which was significantly higher than that of the Korean control population (5.2%) from the previous studies. Patients with gout had more components of metabolic syndrome than did the controls. Body mass index (BMI, OR=1.357 (95%CI 1.111-1.657)) and high density lipoprotein (HDL, OR=0.774 (95%CI 0.705-0.850)) were the variables most significantly associated with the occurrence of metabolic syndrome in gout, but alcohol consumption did not show such associations. Gout is associated with the metabolic syndrome, and furthermore, obesity and dyslipidemia were the factors most associated with the syndrome in these patients.
Adult
;
Aged
;
Body Mass Index
;
Case-Control Studies
;
Gout/*complications
;
Humans
;
Korea/epidemiology
;
Lipoproteins, HDL/blood
;
Male
;
Metabolic Syndrome X/*complications/epidemiology/etiology
;
Middle Aged
;
Multivariate Analysis
;
Risk Factors
9.Interequipment Variability of Doppler Ultrasonographic Indices in Patients with Liver Cirrhosis.
Myeong Gwan JEE ; Soon Koo BAIK ; Dong Hun PARK ; Moon Young KIM ; Dae Wook RHIM ; Ki Won JO ; Jin Hon HONG ; Jae Woo KIM ; Hyun Soo KIM ; Sang Ok KWON
The Korean Journal of Hepatology 2006;12(4):539-545
BACKGROUNDS/AIMS: Doppler ultrasongraphy is used to evaluate hemodynamic alternations in patients with liver cirrhosis. Purpose of this study was to determine the interequipment variability of Doppler indices in portal and splenic vein in cirrhosis. METHODS: Blood velocity, diameter, flow and congestive index in portal and splenic vein were measured by Doppler ultrasonography in 30 patients with cirrhosis using two different machines. RESULTS: Portal venous velocities measured by HDI-5000 and SSD-5000 were 8.72+/-3.69 cm/sec, 12.21+/-2.84 cm/sec, respectively which showed significant difference (P<0.001). Measured portal blood flows and congestive indices also had significant difference between HDI-5000 and SSD-5000 (P<0.01). Splenic venous velocity by HDI-5000 was 8.55+/-2.71 cm/sec, which was lower than that of 12.32+/-3.11 cm/sec by SSD-5000 (P<0.001). Splenic blood flows measured by HDI-5000 and SSD-5000 were 390.73+/-260.98 mL/min, 595.01+/-346.53 mL/min, respectively, showing significant difference (P=0.015). However, no differences were in the diameters of portal and splenic vein between HDI-5000 and SSD-5000. CONCLUSION: Doppler indices in portal and splenic vein showed significant interequipment variability. Therefore, in liver cirrhosis, hemodynamic investigations using different Doppler ultrasonographic machines is inappropriate.
Adult
;
Aged
;
Blood Flow Velocity
;
Female
;
Humans
;
Liver Cirrhosis/*ultrasonography
;
Male
;
Middle Aged
;
Ultrasonography, Doppler/*instrumentation
10.Effect of Galantamine on Caregiver Time and Activities of Daily Living in Mild to Moderate Alzheimer's Disease: A 1-Year Prospective Study.
Guk Hee SUH ; Hee Yeon JUNG ; Chang Uk LEE ; Sang Kyu LEE ; Nam Jin LEE ; Jae Hyun KIM ; Baik Seok KEE ; Dae Gwan KO ; Young Hoon KIM ; In Ja HONG ; Sungku CHOI ; Michael GOLD
Journal of the Korean Geriatrics Society 2007;11(2):74-82
OBJECTIVE: This study aims to investigate the effect of galantamine on caregiver time and activities of daily living(ADLs) in patients with mild to moderate Alzheimer's disease(AD) in a Korean population. DESIGN: Quasi-experimental study: A rndomized, double-blind, parallel-group clinical trial and a naturalistic longitudinal community study METHOD: For this 1-year prospective study, 138 patients residing in the community were recruited(baseline MMSE score of. 10-22). The two groups were composed of 72 patients treated with galantamine and 66 patients selected as the control group from an untreated community cohort of AD patients. The primary efficacy outcome was the caregiver time and the secondary efficacy measure was the Korean version of the Disability Assessment for Dementia(DAD-K) scale. RESULTS: The results of a mixed model analyses demonstrated reduced caregiver time and improved ADLs in galantamine group relative to baseline and compared with the community control group in this 1-year prospective study. Significant improvement in galantamine group observed in the DAD scores demonstrated beneficial effects of galantamine on delaying functional deterioration in patients with mild to moderate AD. Difference in caregiver time between two groups was equivalent to additional 9.5 working days per month or 113 working days per year. CONCLUSION: Treatment with Galantamine is associated with a significantly slower decline in basic and instrumental ADLs in patients with mild to moderated AD. These benefits on functional capacity in patients with AD treated with galantamine were associated with less caregiver time, lower caregiver burden and higher economic benefits.
Activities of Daily Living*
;
Alzheimer Disease*
;
Caregivers*
;
Cohort Studies
;
Galantamine*
;
Humans
;
Prospective Studies*